Active Video Games on Physical Activity (Main Trial)
NCT04116515, Not applicable, Completed, Northeastern University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Active Video Games on Physical Activity (Main Trial) | ClinicalTrials.gov |
| NCT number | NCT04116515 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 135 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Northeastern University | ClinicalTrials.gov |
| Conditions | Physical Inactivity in Children | ClinicalTrials.gov |
| Interventions | Xbox / active video games, Animated cartoon narratives, Standard clinical care | ClinicalTrials.gov |
| First posted | 2019-10-04 | ClinicalTrials.gov |
| Last updated | 2023-03-31 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Changes in objective child physical activity | 6 months | Physical activity will be measured with two 7-day accelerometer worn on the wrist and hip after three visits over 4-6 weeks, including minutes/day MVPA total. Physical activity and time spent in moderate to vigorous physical activity will be measured by two triaxial accelerometer (Actigraph Link and Actigraph GT3X+, Actigraph, Ft. Walton Beach, FL). Children will be asked to wear them for 7 full days during periods. | ClinicalTrials.gov |
| Primary | Changes in fat% | 6 months | Measured through dual-energy X-ray absorptiometry (DEXA) scan by GE Lunar Prodigy (GE Healthcare, Chicago, IL). | ClinicalTrials.gov |
| Primary | Changes in lean tissue% | 6 months | Measured through dual-energy X-ray absorptiometry (DEXA) scan by GE Lunar Prodigy (GE Healthcare, Chicago, IL). | ClinicalTrials.gov |
| Secondary | BMI% | 6 months | The investigators plan to use the weight in kilograms and height in meters from the DEXA scan and children's birthdays and sex to calculate their BMI% using the CDC Calculator. | ClinicalTrials.gov |
| Secondary | Fasting Insulin | 6 months | Analysis of the plasma samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits. | ClinicalTrials.gov |
| Secondary | Fasting Glucose | 6 months | Analysis of the plasma samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits. | ClinicalTrials.gov |
| Secondary | Lipid | 6 months | Analysis of the serum samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits. | ClinicalTrials.gov |
| Secondary | C-reactive protein (CRP) | 6 months | Analysis of the serum samples will be performed using dedicated Enzyme-Linked Immunosorbent Assay (ELISA) kits. | ClinicalTrials.gov |
| Other | Sustained Attention | 6 months | Response time will be measured by the Psychomotor Vigilance Task | ClinicalTrials.gov |
| Other | Working Memory | 6 months | Response time will be measured by the Delayed Match-to-Sample Task | ClinicalTrials.gov |
| Other | Working Memory | 6 months | Response accuracy will be measured by the Delayed Match-to-Sample Task | ClinicalTrials.gov |
| Other | Inhibitory Control | 6 months | Response time will be measured by the Stroop Test | ClinicalTrials.gov |
| Other | Inhibitory Control | 6 months | Response accuracy will be measured by the Stroop Test | ClinicalTrials.gov |
| Other | Physical Activity Motivation | 6 months | Physical Activity Motivation will be measured by the Physical Activity Motivation scale through self-report | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 40420195 | DERIVED | PubMed |
Grants 1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|---|---|---|---|---|---|
| R01DK109316 | The Narrative Effect of Active Video Games on Long-term Moderate-to-Vigorous Physical Activity | LU, AMY SHIRONG | NORTHEASTERN UNIVERSITY | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2016 to 2020 | NIH RePORTER |
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Delayed Match-to-Sample | Other outcome | ConductCognition |
| Psychomotor Vigilance Task | Other outcome | ConductCognition |
| Stroop Color-Word Test | Other outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)